In epigenetic therapy, less is more
- PMID: 22482500
- DOI: 10.1016/j.stem.2012.03.012
In epigenetic therapy, less is more
Abstract
How DNA methylation inhibitors exert their anticancer effects in patients is not well understood. In the latest issue of Cancer Cell, Tsai et al. (2012) use low-dose drug treatment to induce persistent attenuation of tumorigenicity by targeting tumor-initiating cells.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment on
-
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.Cancer Cell. 2012 Mar 20;21(3):430-46. doi: 10.1016/j.ccr.2011.12.029. Cancer Cell. 2012. PMID: 22439938 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources